Company research
MARIMED INC.
CIK 1522767Updated Sep 24, 2026
SecuritiesMRMD · CSE · equityMRMD · OTC · equity
Historical securities (1)
MRMD · NEO · equity · closed Oct 1, 2024Name history
WORLDS ONLINE INC. · through May 15, 2017
MRMD price & chart
Loading TradingView…
CSE:MRMD on TradingView ↗About the company
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.
In the news
No coverage from other publishers is available.
Recent filings
Other Events
Items 8.01, 9.01
DEF 14A filing
PRE 14A filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 202,565,000Source | 206,989,000Source | 196,123,000Source | 152,202,000Source |
| Property, Plant and Equipment, NetUSD | 89,385,000Source | 94,167,000Source | 89,103,000Source | 71,641,000Source |
| GoodwillUSD | 24,002,000Source | 15,812,000Source | 11,993,000Source | 8,079,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 7,282,000Source | 14,645,000Source | 9,737,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 9,114,000Source | 8,742,000Source | 7,199,000Source | 4,157,000Source |
| Inventory, NetUSD | 36,601,000Source | 33,488,000Source | 25,306,000Source | 19,477,000Source |
| Assets, CurrentUSD | 59,290,000Source | 53,509,000Source | 51,432,000Source | 44,146,000Source |
| Operating Lease, Right-of-Use AssetUSD | 7,723,000Source | 8,730,000Source | 9,716,000Source | 4,931,000Source |
| Other Assets, NoncurrentUSD | 931,000Source | 11,219,000Source | 12,537,000Source | 1,024,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 137,831,000Source | 128,113,000Source | 107,209,000Source | 57,167,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 397,000Source | 381,000Source | 375,000Source | 341,000Source |
| Additional Paid in CapitalUSD | 179,405,000Source | 173,366,000Source | 171,144,000Source | 142,365,000Source |
| Retained Earnings (Accumulated Deficit)USD | -127,932,000Source | -112,119,000Source | -99,955,000Source | -83,924,000Source |
| Liabilities and EquityUSD | 202,565,000Source | 206,989,000Source | 196,123,000Source | 152,202,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 59,067,000Source | 48,678,000Source | 30,862,000Source | 26,490,000Source |
| Operating Lease, Liability, CurrentUSD | 1,952,000Source | 1,988,000Source | 1,945,000Source | 1,273,000Source |
| Accounts Payable, CurrentUSD | 14,586,000Source | 13,189,000Source | 9,001,000Source | 6,626,000Source |
| Operating Lease, Liability, NoncurrentUSD | 6,616,000Source | 7,549,000Source | 8,455,000Source | 4,173,000Source |
| Other Liabilities, NoncurrentUSD | 0Source | 100,000Source | 100,000Source | 100,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -1,861,000Source | -1,752,000Source | -1,650,000Source | -1,511,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 9,509,000Source | 4,435,000Source | 3,549,000Source | 3,091,000Source |
| Long-term DebtUSD | 76,042,000Source | 78,187,000Source | — | — |
| Short-term InvestmentsUSD | — | 0Source | 88,000Source | 123,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -14,456,000Source | -12,127,000Source | -16,007,000Source | 13,614,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,860,000Source | 1,050,000Source | 1,020,000Source | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 429,000Source | 1,207,000Source | 3,160,000Source | 6,902,000Source |
| Increase (Decrease) in InventoriesUSD | 6,000Source | 8,182,000Source | 5,829,000Source | 5,383,000Source |
| Increase (Decrease) in Accounts PayableUSD | 841,000Source | 4,188,000Source | 2,375,000Source | 1,027,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 7,695,000Source | 6,785,000Source | 7,910,000Source | 7,311,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | -231,000Source | 4,250,000Source | 2,987,000Source | 12,847,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,380,000Source | -17,133,000Source | -25,985,000Source | -26,244,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,167,000Source | 11,960,000Source | 20,130,000Source | 12,140,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -4,713,000Source | 2,985,000Source | 22,983,000Source | -1,013,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 1,602,000Source | -7,363,000Source | 4,908,000Source | -19,946,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 8,884,000Source | — | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 6,910,000Source | 6,689,000Source | 5,654,000Source | 1,744,000Source |
| Income Taxes Paid, NetUSD | -713,000Source | 877,000Source | 6,419,000Source | 14,567,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | 73,000Source | 73,000Source | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | 2,100,000Source | 2,100,000Source | — |
| Amortization of Intangible AssetsUSD | 3,401,000Source | 2,948,000Source | 3,025,000Source | 1,282,000Source |
| Debt and Equity Securities, Gain (Loss)USD | — | — | — | 0Source |
| DepreciationUSD | 8,100,000Source | 7,900,000Source | 5,500,000Source | 3,432,000Source |
| Gain (Loss) on InvestmentsUSD | 0Source | -145,000Source | -76,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -834,000Source | -13,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | 0Source | -10,431,000Source | — |
| General and Administrative ExpenseUSD | 26,142,000Source | 25,618,000Source | 22,132,000Source | 20,735,000Source |
| GoodwillUSD | 24,002,000Source | 15,812,000Source | 11,993,000Source | 8,079,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 3,594,000Source | 8,159,000Source | 9,411,000Source | 5,894,000Source |
| InterestExpenseNonoperatingUSD | 7,502,000Source | 6,944,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -14,484,000Source | -12,164,000Source | -16,031,000Source | 13,468,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 28,000Source | 37,000Source | 24,000Source | 146,000Source |
| Nonoperating Income (Expense)USD | -8,042,000Source | -6,880,000Source | -20,981,000Source | -861,000Source |
| Operating ExpensesUSD | 60,701,000Source | 59,956,000Source | 51,534,000Source | 43,588,000Source |
| Operating Lease, ExpenseUSD | 285,000Source | 233,000Source | 272,000Source | 156,000Source |
| Operating Lease, Lease IncomeUSD | — | 1,100,000Source | 1,787,000Source | 3,526,000Source |
| Other Nonoperating Income (Expense)USD | -717,000Source | -50,000Source | -1,635,000Source | -127,000Source |
| Proceeds from Stock Options ExercisedUSD | — | 0Source | 109,000Source | 10,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | -1,082,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 159,826,000Source | 157,964,000Source | 148,598,000Source | 134,010,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -2,820,000Source | 2,912,000Source | 14,385,000Source | 20,369,000Source |
| Other Nonoperating Income (Expense)USD | -717,000Source | -50,000Source | -1,635,000Source | -127,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -10,862,000Source | -3,968,000Source | -6,596,000Source | 19,508,000Source |
| Income Tax Expense (Benefit)USD | 3,594,000Source | 8,159,000Source | 9,411,000Source | 5,894,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 28,000Source | 37,000Source | 24,000Source | 146,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,484,000Source | -12,164,000Source | -16,031,000Source | 13,468,000Source |
| Earnings Per Share, BasicUSD per share | -0.04Source | -0.03Source | -0.04Source | 0.04Source |
| Earnings Per Share, DilutedUSD per share | -0.04Source | -0.03Source | -0.04Source | 0.04Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 390,135,000Source | 379,153,000Source | 363,403,000Source | 337,697,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 390,135,000Source | 379,153,000Source | 363,403,000Source | 380,289,000Source |
| Interest Expense (non-operating)USD | 7,502,000Source | 6,944,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 3,401,000Source | 2,948,000Source | 3,025,000Source | 1,282,000Source |
| Business Combination, Acquisition Related CostsUSD | 486,000Source | 951,000Source | 695,000Source | 961,000Source |
| Current Income Tax Expense (Benefit)USD | 3,594,000Source | — | — | — |
| Debt and Equity Securities, Gain (Loss)USD | — | — | — | 0Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 8,109,000Source | 7,910,000Source | 5,549,000Source | — |
| Gain (Loss) on InvestmentsUSD | 0Source | -145,000Source | -76,000Source | — |
| General and Administrative ExpenseUSD | 26,142,000Source | 25,618,000Source | 22,132,000Source | 20,735,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | 57,881,000Source | 62,868,000Source | 65,919,000Source | 63,957,000Source |
| Interest ExpenseUSD | — | — | 9,185,000Source | 1,693,000Source |
| Interest Income, OtherUSD | 177,000Source | 114,000Source | 270,000Source | 959,000Source |
| Labor and Related ExpenseUSD | 28,515,000Source | 27,059,000Source | 22,612,000Source | 14,404,000Source |
| Marketing and Advertising ExpenseUSD | 3,976,000Source | 6,664,000Source | 5,977,000Source | 3,736,000Source |
| Nonoperating Income (Expense)USD | -8,042,000Source | -6,880,000Source | -20,981,000Source | -861,000Source |
| Operating ExpensesUSD | 60,701,000Source | 59,956,000Source | 51,534,000Source | 43,588,000Source |
| Operating Lease, ExpenseUSD | 285,000Source | 233,000Source | 272,000Source | 156,000Source |
| Operating Lease, Lease IncomeUSD | — | 1,100,000Source | 1,787,000Source | 3,526,000Source |
Filing attachments
ex-42promissorynote2.htm · 8-K · 2026-03-02
EX-4.2 4 ex-42promissorynote2.htm EX-4.2 ex-42promissorynote2 Execution Version THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR AN OPINION OF COUNSEL, IN FORM, SUBSTANCE AND SCOPE REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR UNLESS …
Read attachment ↗ex41promissorynote1.htm · 8-K · 2026-03-02
EX-4.1 3 ex41promissorynote1.htm EX-4.1 ex41promissorynote1 Execution Version THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR AN OPINION OF COUNSEL, IN FORM, SUBSTANCE AND SCOPE REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR UNLESS SO…
Read attachment ↗marimedq32025ex991.htm · 8-K · 2025-11-05
EX-99.1 2 marimedq32025ex991.htm EX-99.1 Document Exhibit 99.1 MariMed Reports Third Quarter 2025 Earnings NORWOOD, MA, November 5, 2025 - MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the third quarter ended September 30, 2025. Management Commentary “During the third quarter, we continued to make progress on our plan to own top-selling, national…
Read attachment ↗marimedq22025ex991.htm · 8-K · 2025-08-06
EX-99.1 2 marimedq22025ex991.htm EX-99.1 Document Exhibit 99.1 MariMed Reports Second Quarter 2025 Earnings NORWOOD, MA, August 6, 2025 - MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended June 30, 2025. Management Commentary “We delivered growth and expanded operations across our business during the second quarter, continuing…
Read attachment ↗marimedq12025ex991.htm · 8-K · 2025-05-07
EX-99.1 2 marimedq12025ex991.htm EX-99.1 Document Exhibit 99.1 MariMed Reports First Quarter 2025 Earnings NORWOOD, MA, May 7, 2025 - MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2025. Management Commentary “We are executing on our vision to build the best consumer packaged goods company in cannabis, and over th…
Read attachment ↗